Sharsheret, Israel 
June 6, 1012

Morflora, focused on innovative non-transgenic, non-heritable, trait delivery technology for plant protection and enhancement, announced today that Biense Visser and Gabi Unger have joined the company’s Advisory Board.

Dotan Peleg, Morflora’s CEO commented, "Morflora adapted its innovative trait delivery technology to the market by developing a revolutionary yet simple treatment which makes it applicable to seeds. This effort was successfully stirred by the scientists in our advisory board, Prof. Haim Rabinowitch and Prof. Ilan Sela. As the technology matures and as we tap into the market, we have expanded our advisory board with industry veterans to advance our commercialization strategy.”

Currently Chairman of the Management Board and Chief Executive Officer of aap Implantate AG, Mr. Visser has rich executive experience in the agri-bio and pharmaceutical industries. In one of his prior positions Visser was the CEO of De Ruiter Seeds Group, Netherlands, a family-owned company which engages in breeding, producing, marketing, distributing, and selling vegetable seeds primarily in Europe. The company was successfully sold for 546M Euro, 15 times EBITDA to Monsanto. Mr. Visser also served as President of Teva Europe and member of the board of Teva Pharmaceuticals (NASDAQ:TEVA). He holds an MBA at Business from Universiteit Nyenrode, Netherlands and a graduated from the faculty of Pharmacy at Rijksuniversiteit Utrecht, Netherlands.

Also joining Morflora’s advisory board is Mr. Gabi Unger, a seasoned executive, bringing over 25 years experience in the Agriculture industry. In his recent position Mr. Unger served as the CEO of AB Seeds, and led the company through an acquisition with De Ruiter Seeds, which was later acquired by Monsanto. In former positions, Unger served as CEO for ‘Field Produce’, a leading exporter of dry fruit, and marketing manager of KOFFOLK, largest feed additives producer in Israel (a FIBRO Inc. Member). Mr. Unger earned his B.A in Agronomy from the Hebrew University of Jerusalem, and is an MBA graduate from the Tel Aviv College.

Morflora, an innovator in the agricultural biotechnology industry, develops technology to help growers and seed companies worldwide promote sustainable agriculture and fight against common diseases and threats to crops via non-transgenic effective solutions. The company’s TraitUP™ platform is utilized to express or silence genes in seeds and plants, and acquired traits are expresses within days post treatment.

“We are delighted to welcome Biense and Gabi to our Advisory board. They both bring with them experience from executive management positions in international companies as well as specialized experience in the seed industry. Their contribution will be invaluable to Morflora as we continue the development of our innovative solutions and gain foothold in the markets." Peleg added.

Morflora was recently selected as a winner in the 2012 Red Herring 100 Europe award competition, a prestigious list honoring the year’s most promising private technology ventures from the European business region. Morflora was selected based on the company’s unique agri-bio technology innovation, reconfirming the company’s potential to bring about a revolutionary solution.

Morflora develops generic and non transgenic trait delivery solutions into plants, to protect them from a wide variety of diseases, as well as introduce new desired traits for plant enhancement. The company targets the seed and plant treatment markets, offering technology and solutions to increase global crop yield and reduce dependency on chemical treatments and lengthy breeding processes. Established in 2008, Morflora’s mission is to become a leading supplier of plant protection and enhancement solutions for a variety of agricultural markets. Morflora and Yissum Research Development Company, the technology transfer arm of the Hebrew University of Jerusalem, co-own the TraitUP™ patents, and Morflora holds an exclusive license to commercialize the technology.

Website: http://www.morflora.com/

Published: June 6, 2012